Cyclacel Pharmaceuticals, Inc. Financial Ratios — CYCC Stock

Profitability (USD)

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-69.77	-53.06	-58.15	-37	-59.74	-52.97	-53.08	-32.72	-31.81	-44.58	-32.41	-46.18	-59.56	-122.4	-173.84
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	- -	100	100	100	100	100	- -	100	- -	- -	- -	- -	100	100
EBITDA Margin (%)	-13,105.36	- -	-21,801.45	-1,651.66	-1,283.91	-820.99	-1,662.75	- -	-6,346	- -	- -	- -	- -	-6,052.86	-27,902.33
Operating Margin (%)	-13,513.39	- -	-21,888.41	-1,658.12	-1,293.94	-831.79	-1,678.53	- -	-6,365.33	- -	- -	- -	- -	-6,060.24	-27,916.28
Incremental Operating Margin (%)	- -	547.32	- -	- -	- -	- -	- -	-552.67	- -	89.33	- -	- -	- -	- -	- -
Pretax Margin (%)	-13,881.25	- -	-21,894.2	-1,095.94	-1,306.17	-848.05	-1,633.93	- -	-5,750	- -	- -	- -	- -	-6,083.57	-27,893.02
Profit Margin (%)	-14,304.46	- -	-19,110.14	-936.62	-1,118.05	-737.76	-1,398.7	- -	-4,858.67	- -	- -	- -	- -	-5,370.24	-26,074.42
Net Income to Common Margin (%)	-17,591.96	- -	-20,165.22	-1,796.86	-1,129.58	-748.1	-1,422.42	- -	-4,992.67	- -	- -	- -	- -	-5,418.1	-26,074.42
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	19.83	2.37	5.03	46.17	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.12	-0.1	- -	- -	- -	- -
Net Debt/EBITDA	2.01	1.58	1.09	1.74	1.09	1.28	1.18	2.53	1.84	1.23	3.15	1.64	0.66	0.13	0.26
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.12	-0.1	- -	- -	- -	- -
Net Debt/EBIT	1.95	1.55	1.09	1.73	1.08	1.26	1.17	2.52	1.83	1.23	3.14	1.63	0.66	0.13	0.26
EBITDA to Interest Expense	-341.35	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-341.53	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-351.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-768.54	-988.75	-1,396.31	-814.78	-1,050.78	-1,304.94	-1,703.97	-1,317.14	-1,764.54	-2,336.2	-994.69	-891.41	-1,430.42	-4,864.07	-10,734.86
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.18	3.18	0.08	0.52	6.1	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.33	-0.29	-0.01	-0.03	-0.01	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.78	2.87	0.07	0.38	0.42	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.18	3.18	0.08	0.52	6.1	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.33	-0.29	-0.01	-0.03	-0.01	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.78	2.87	0.07	0.38	0.42	- -
Net Debt to Equity	-118.34	-125.38	-163.81	-111.14	-111.53	-108.52	-115.74	-109.85	-114.61	-101.61	-100.44	-96.99	-89.78	-556.51	144.3
Net Debt/Capital (%)	10.87	8.69	5.73	9.72	7.26	5.95	4.7	6.53	4.77	3.23	8.38	8.68	4.37	0.78	0.71
EBITDA	-15	-16	-15	-18	-22	-16	-14	-9	-10	-10	-11	-22	-28	-25	-12
EBITDA-CapEx	-15	-16	-15	-18	-23	-16	-14	-9	-10	-10	-11	-22	-28	-25	-12
Operating Income (Loss)	-15	-16	-15	-18	-22	-16	-14	-9	-10	-10	-11	-22	-28	-25	-12

Liquidity (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Cash Ratio	4.51	3.76	1.76	4.29	3.23	3.55	3.14	5.81	3.93	4.91	13.44	6.75	2.44	0.41	0.5
Current Ratio	4.75	3.98	2.02	4.85	3.87	4.27	3.73	6.32	4.45	5.79	14.27	7.56	3.25	0.91	0.59
Quick Ratio	4.51	3.76	1.76	4.61	3.69	4.08	3.53	6.17	4.19	5.46	13.97	7.55	3.19	0.87	0.54
CFO/Avg Current Liab	-2.12	-2.14	-1.52	-2.19	-2.54	-2.18	-1.83	-1.6	-1.56	-2.75	-3.23	-4.69	-3.22	-2.06	-1.11
Common Equity/Total Assets	-768.54	-988.75	-1,396.31	-814.78	-1,050.78	-1,304.94	-1,703.97	-1,317.14	-1,764.54	-2,336.2	-994.69	-891.41	-1,430.42	-4,864.07	-10,734.86
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.18	3.18	0.08	0.52	6.1	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.33	-0.29	-0.01	-0.03	-0.01	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.78	2.87	0.07	0.38	0.42	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.18	3.18	0.08	0.52	6.1	- -
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.33	-0.29	-0.01	-0.03	-0.01	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.78	2.87	0.07	0.38	0.42	- -
CFO/Total Liabilities	-245.51	-215.1	-129.01	-242.75	-242.91	-243.89	-187.03	-176.54	-147.24	-261.62	-223.93	-340.62	-273.43	-196.54	-127.47
CFO/CapEx	-2,005.5	-2,329.5	-1,003.58	-87.5	-60.52	-425.29	-3,359.67	-575.38	-171.82	-944.7	-82.65	-686.67	-2,975.29	-2,685.33	- -
Altman's Z-Score	-11.03	-14.77	-21.3	-11.7	-16.21	-19.31	-25.14	-18.44	-25.29	-33.76	-13.48	-12.95	-22.74	-77.68	-160.7

Working Capital (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Accounts Receivable Turnover	- -	- -	- -	6.07	7.06	8.45	5.17	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	60.1	51.68	43.18	70.58	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.02	- -	-0.09	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	21,597.93	78,475	-3,986.92	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Market Capitalization	4	2	3	5	1	1	1	1	1	1	2	2	- -	- -	- -
- Cash & Cash Equivalents	29	24	16	31	24	20	17	24	18	12	33	37	18	3	3
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	- -
Enterprise Value	-25	-23	-13	-26	-23	-19	-15	-23	-17	-10	-30	-34	-18	-3	-3
Total Capital	-242	-257	-270	-289	-309	-323	-335	-342	-350	-356	-365	-384	-401	-428	-439
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.33	-0.29	-0.01	-0.03	-0.01	- -
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.12	-0.03	- -	-0.01	-0.01	- -
EV/Sales	345.18	- -	520.9	43.03	127.81	123.44	7.09	- -	660.37	- -	- -	- -	- -	78.59	4.56
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	4	2	3	5	1	1	1	1	1	1	2	2	- -	- -	- -
Diluted Enterprise Value	-25	-23	-13	-26	-23	-19	-15	-23	-17	-10	-30	-34	-18	-3	-3
EV per Share	336,175.23	55,416.4	239,614.45	138,832.37	36,343.53	26,536.81	6,746.4	7,412.03	2,457.16	70.71	1,740.85	872.21	135.21	38.79	0.35
TTM Sales	- -	- -	- -	1	2	2	1	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-15	-16	-15	-18	-22	-16	-14	-9	-10	-10	-11	-22	-28	-25	-12
TTM Operating Income	-15	-16	-15	-18	-22	-16	-14	-9	-10	-10	-11	-22	-28	-25	-12
TTM Cash Flow to Firm	-16	-14	-12	-18	-19	-14	-10	-7	-7	-9	-8	-19	-21	-16	-8
TTM Free Cash Flow to Firm	-16	-14	-12	-18	-18	-14	-10	-7	-7	-9	-8	-19	-21	-16	-8

Multiples (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Price/Free Cash Flow	-0.26	-0.14	-0.29	-0.28	-0.06	-0.08	-0.15	-0.19	-0.08	-0.08	-0.24	-0.13	-0.02	-0.01	-0.03
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-25	-23	-13	-26	-23	-19	-15	-23	-17	-10	-30	-34	-18	-3	-3
Low Price	403,200	145,152	157,248	158,400	35,136	27,141.12	14,640	7,182.24	2,448	1,350.24	748.8	756	127.87	35.2	4.96
EV/Sales	345.18	- -	520.9	43.03	127.81	123.44	7.09	- -	660.37	- -	- -	- -	- -	78.59	4.56
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-0.27	-0.22	-0.18	-0.27	-0.25	-0.12	-0.12	-0.35	-0.16	-0.09	-0.18	-0.19	-0.07	-0.02	-0.08
Price/Earnings High	-0.58	-0.37	-0.34	-0.41	-0.37	-0.35	-0.23	-1.13	-0.21	-0.17	-0.55	-0.36	-0.16	-0.04	-0.21
Price/Earnings Low	-0.14	-0.07	-0.11	-0.18	-0.05	-0.08	-0.07	-0.16	-0.06	-0.04	-0.09	-0.1	-0.02	-0.01	-0.02
Price/Book Value	-0.02	-0.01	-0.01	-0.02	- -	- -	- -	- -	- -	- -	-0.01	-0.01	- -	- -	- -
Price/Book Value Average	-0.02	-0.01	-0.01	-0.02	-0.02	-0.01	- -	-0.01	- -	- -	- -	-0.01	- -	- -	- -
Price/Book Value High	-0.05	-0.02	-0.02	-0.03	-0.02	-0.02	-0.01	-0.03	- -	- -	-0.01	-0.02	-0.01	- -	-0.01
Price/Book Value Low	-0.01	- -	-0.01	-0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	0.17	0.1	0.35	0.18	0.05	0.06	0.1	0.06	0.03	0.07	0.06	0.06	0.02	0.25	-0.1
Price/Tangible Book Value Average	0.22	0.18	0.26	0.19	0.22	0.09	0.1	0.12	0.08	0.06	0.05	0.1	0.07	0.81	-0.43
Price/Tangible Book Value High	0.46	0.3	0.47	0.28	0.33	0.27	0.19	0.4	0.1	0.12	0.14	0.18	0.17	1.64	-1.09
Price/Tangible Book Value Low	0.11	0.06	0.16	0.12	0.04	0.06	0.06	0.05	0.03	0.03	0.02	0.05	0.02	0.21	-0.08
Price/Sales	37.04	- -	50.58	4.7	0.6	0.61	1.78	- -	3.33	- -	- -	- -	- -	0.36	5.17
Price/Sales Average	48.2	- -	37.07	4.87	2.8	0.87	1.64	- -	7.81	- -	- -	- -	- -	1.18	21.71
Price/Sales High	102.82	- -	68.29	7.32	4.18	2.59	3.27	- -	10.68	- -	- -	- -	- -	2.37	54.94
Price/Sales Low	25.2	- -	22.79	3.21	0.53	0.57	1.02	- -	2.82	- -	- -	- -	- -	0.3	4.26
Price/Cash Flow	-0.26	-0.14	-0.29	-0.28	-0.06	-0.08	-0.15	-0.19	-0.07	-0.08	-0.24	-0.12	-0.02	-0.01	-0.03
Price/Cash Flow Average	-0.34	-0.25	-0.21	-0.29	-0.26	-0.12	-0.14	-0.36	-0.17	-0.07	-0.2	-0.2	-0.07	-0.03	-0.12
Price/Cash Flow High	-0.72	-0.42	-0.39	-0.44	-0.39	-0.35	-0.27	-1.16	-0.24	-0.14	-0.6	-0.37	-0.16	-0.06	-0.3
Price/Cash Flow Low	-0.18	-0.08	-0.13	-0.19	-0.05	-0.08	-0.09	-0.16	-0.06	-0.03	-0.1	-0.1	-0.02	-0.01	-0.02
Price/Free Cash Flow Average	-0.34	-0.25	-0.21	-0.29	-0.26	-0.12	-0.14	-0.36	-0.18	-0.07	-0.2	-0.2	-0.07	-0.03	-0.12
Price/Free Cash Flow High	-0.72	-0.42	-0.39	-0.44	-0.39	-0.35	-0.27	-1.16	-0.24	-0.14	-0.61	-0.37	-0.16	-0.06	-0.3
Price/Free Cash Flow Low	-0.18	-0.08	-0.13	-0.19	-0.05	-0.08	-0.09	-0.16	-0.06	-0.03	-0.1	-0.1	-0.02	-0.01	-0.02
EV/Sales Average	528.53	- -	318.15	45.69	29.39	2.56	5.06	- -	1,703.24	- -	- -	- -	- -	9.7	252.75
EV/Sales High	1,425.78	- -	786.44	83.03	50.67	28.43	29.44	- -	38.88	- -	- -	- -	- -	27.6	751.15
EV/Sales Low	150.66	- -	104	20.37	109.61	115.74	178.66	- -	541.21	- -	- -	- -	- -	63.35	- -
EV/EBITDA Average	1.64	1.35	0.92	1.44	0.87	1.17	1.08	2.25	1.72	1.04	2.9	1.47	0.61	0.11	0.18
EV/EBITDA High	1.22	1.19	0.78	1.3	0.76	0.97	0.98	1.61	1.67	0.97	2.6	1.33	0.54	0.09	0.06
EV/EBITDA Low	1.82	1.5	0.99	1.54	1.05	1.21	1.12	2.4	1.79	1.07	2.98	1.55	0.65	0.13	0.25
EV/EBIT Average	1.59	1.33	0.92	1.44	0.86	1.16	1.07	2.24	1.71	1.03	2.9	1.47	0.61	0.11	0.18
EV/EBIT High	1.19	1.18	0.77	1.29	0.76	0.95	0.97	1.6	1.67	0.97	2.6	1.33	0.54	0.09	0.06
EV/EBIT Low	1.76	1.48	0.98	1.54	1.04	1.2	1.11	2.39	1.79	1.07	2.97	1.55	0.65	0.13	0.25
Last Price	592,644.8	237,864.16	349,021.12	231,528.8	40,310.24	28,797.12	25,392	8,352	2,891.36	3,216	1,874.4	933.6	159.52	42.72	6.02
High Price	1,645,056	741,888	471,168	360,576	278,726.4	122,688	46,656	52,320	9,264	5,664	4,703.36	2,740.8	1,086	280.8	64
Enterprise Value Average	-24	-21	-14	-26	-19	-19	-15	-21	-16	-10	-31	-33	-17	-3	-2
Enterprise Value High	-18	-19	-12	-23	-17	-15	-14	-15	-16	-9	-28	-30	-15	-2	-1
Enterprise Value Low	-27	-23	-15	-28	-23	-19	-16	-23	-17	-10	-32	-35	-18	-3	-3

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	16,000	- -	6,900	49,272.73	66,692.31	47,414.63	14,288.14	- -	867.05	- -	- -	- -	- -	118.48	1.16
EBITDA per Share	-2,096,857.14	-1,938,375	-1,504,300	-813,818.18	-856,269.23	-389,268.29	-237,576.27	-56,981.93	-55,023.12	-40,596.64	-10,521.31	-9,014.12	-8,836.85	-7,171.23	-325.03
Operating Income per Share	-2,162,142.86	-1,968,500	-1,510,300	-817,000	-862,961.54	-394,390.24	-239,830.51	-57,174.7	-55,190.75	-40,680.67	-10,541.13	-9,031.46	-8,847.09	-7,179.97	-325.2
Basic EPS, GAAP	-2,814,714.29	-1,996,375	-1,391,400	-885,363.64	-753,346.15	-354,707.32	-203,237.29	-46,210.84	-43,289.02	-33,743.7	-8,568.88	-7,526.42	-6,845.49	-6,419.18	-303.74
Basic EPS from Cont Ops	-2,127,142.86	-1,825,375	-1,375,600	-464,090.91	-746,384.62	-349,804.88	-199,847.46	-45,000	-42,127.17	-32,899.16	-8,369.67	-7,445.34	-6,781.19	-6,362.48	-303.74
Diluted EPS, GAAP	-2,814,714.29	-1,996,375	-1,391,400	-885,363.64	-753,346.15	-354,707.32	-203,237.29	-46,210.84	-43,289.02	-33,743.7	-8,568.88	-7,526.42	-6,845.49	-6,419.18	-303.74
Diluted EPS from Cont Ops	-2,127,142.86	-1,825,375	-1,375,600	-464,090.91	-746,384.62	-349,804.88	-199,847.46	-45,000	-42,127.17	-32,899.16	-8,369.67	-7,445.34	-6,781.19	-6,362.48	-303.74
Dividend per Share	- -	45,500	- -	13,863.64	7,692.31	4,902.44	3,389.83	1,210.84	1,161.85	844.54	199.21	81.08	64.3	56.7	- -
Cash Flow per Share	-2,292,000	-1,747,125	-1,204,300	-827,227.27	-719,307.69	-352,682.93	-170,830.51	-45,060.24	-38,734.1	-39,693.28	-7,863.23	-7,478.82	-6,662.51	-4,544.99	-216.45
Free Cash Flow per Basic Share	-2,293,142.86	-1,747,875	-1,205,500	-836,681.82	-731,192.31	-353,512.2	-170,881.36	-45,138.55	-38,959.54	-39,735.29	-7,958.37	-7,489.71	-6,664.75	-4,546.69	-216.45
Cash & Equivalents per Share	4,213,571.43	3,056,125	1,641,200	1,415,727.27	930,346.15	498,536.59	280,000	144,036.14	101,179.19	49,936.97	33,108.03	14,747.48	5,868.52	952.89	84.98
Book Value per Share	-34,539,142.86	-32,132,000	-27,024,100	-13,155,045.45	-11,876,692.31	-7,881,853.66	-5,678,559.32	-2,063,234.94	-2,021,878.61	-1,502,630.25	-362,800.79	-155,110.53	-128,353.17	-120,812.69	-11,905.97
Tangible Book Value per Share	3,560,428.57	2,437,375	1,001,800	1,273,772.73	834,153.85	459,390.24	241,915.25	131,120.48	88,277.46	49,147.06	32,962.34	15,204.92	6,536.47	171.23	-58.9

Cyclacel Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)